IBEX CEO sells 25,000 shares at about $40

Rhea-AI Filing Summary

IBEX Ltd (IBEX) reports that Chief Executive Officer and director Robert Thomas Dechant sold 25,000 Common Shares on September 15, 2026 in an open-market or private transaction at a weighted average price of $39.9867 per share, and now directly holds 262,011 Common Shares. No Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Net Seller: 25,000 shares

Net Sell 1 txn

Insider Dechant Robert Thomas

Role Chief Executive Officer

Sold 25,000 shs ($1000K)

Type	Security	Shares	Price	Value
Sale	Common Shares F1	25,000	$39.9867	$1000K

Holdings After Transaction: Common Shares — 262,011 shares (Direct)

Footnotes (1)

1. F1. This transaction was executed in multiple trades at prices ranging from $39.86 to $40.29; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Key Figures

Shares sold: 25,000 shares Weighted average sale price: $39.9867 per share Post-transaction holdings: 262,011 shares +2 more

5 metrics

Shares sold 25,000 shares Common Shares sold by CEO on September 15, 2026

Weighted average sale price $39.9867 per share Average price for the 25,000 shares sold on September 15, 2026

Post-transaction holdings 262,011 shares Common Shares directly held by CEO after the sale

Trade price range $39.86–$40.29 per share Price range of multiple trades comprising the reported sale

Net buy/sell shares 25,000 shares net sold Net sell direction across all transactions in this Form 4

Key Terms

weighted average sales price, open market or private transaction, Form 4

3 terms

weighted average sales price financial

"the price reported above reflects the weighted average sales price"

open market or private transaction financial

"Sale in open market or private transaction"

Form 4 regulatory

"reported in a Form 4 by CEO and director Robert Thomas Dechant"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did IBEX (IBEX) report for its CEO?

IBEX reported that CEO and director Robert Thomas Dechant sold 25,000 Common Shares on September 15, 2026 in an open-market or private transaction, as disclosed in a Form 4 filing.

At what price did the IBEX CEO sell the 25,000 shares?

The 25,000 IBEX shares were sold at a weighted average price of $39.9867 per share, with individual trade prices ranging from $39.86 to $40.29, according to the Form 4 footnote.

How many IBEX (IBEX) shares does the CEO hold after this sale?

After the reported sale, Robert Thomas Dechant directly holds 262,011 IBEX Common Shares, as stated in the Form 4 under total shares following the transaction.

Was the IBEX CEO’s September 15, 2026 share sale under a Rule 10b5-1 plan?

No. The Form 4 indicates the Rule 10b5-1 checkbox is not affirmed, and there is no footnote stating that the September 15, 2026 sale was made under a Rule 10b5-1 trading plan.

How was the IBEX CEO’s sale of 25,000 shares executed?

The Form 4 footnote states the sale was executed in multiple trades at prices ranging from $39.86 to $40.29, and that the $39.9867 figure reported is the weighted average sales price for those trades.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/16/2026 - 05:15 PM Accepted by SEC EDGAR 09/16/2026 - 05:14 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dechant Robert Thomas

(Last) (First) (Middle)

C/O IBEX LIMITED

1717 PENNSYLVANIA AVENUE NW, SUITE 825

(Street)

WASHINGTON DISTRICT OF COLUMBIA 20006

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
IBEX Ltd [ IBEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	09/15/2026		S		25,000	D	$39.9867(1)	262,011	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $39.86 to $40.29; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Remarks:

	Lisa Lenstrohm, Attorney-in-Fact	09/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)